Cargando…

Detecting Drug-Drug Interactions in COVID-19 Patients

COVID-19 patients with multiple comorbid illnesses are more likely to be using polypharmacy to treat their COVID-19 disease and comorbid conditions. Previous literature identified several DDIs in COVID-19 patients; however, various DDIs are unrecognized. This study aims to discover novel DDIs by con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Eugene, Person, Anna K., Stollings, Joanna L., Su, Yu, Li, Lang, Chen, You
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208760/ https://www.ncbi.nlm.nih.gov/pubmed/35673029 http://dx.doi.org/10.3233/SHTI220090

Ejemplares similares

Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system
por: Jeong, Eugene, et al.
Publicado: (2022)

Revealing the dynamic landscape of drug-drug interactions through network analysis
por: Jeong, Eugene, et al.
Publicado: (2023)

Drug-drug interactions in patients with COVID-19
Publicado: (2020)

Drug–Drug Interactions in Patients with COVID-19 in Nursing Homes
por: Correard, Florian, et al.
Publicado: (2021)

Pharmacokinetic Drug–Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients
por: Karaźniewicz-Łada, Marta, et al.
Publicado: (2021)

Antimicrobial exposure and the risk of delirium in critically ill patients
por: Grahl, Jessica J., et al.
Publicado: (2018)

COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions
por: Back, David, et al.
Publicado: (2020)

Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
por: Spanakis, Marios, et al.
Publicado: (2022)

Detection of Potential Drug-Drug Interactions for Outpatients across Hospitals
por: Yeh, Yu-Ting, et al.
Publicado: (2014)

Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
por: Kumar, Devendra, et al.
Publicado: (2021)

Potential drug–drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir()
por: Brandariz-Nuñez, David, et al.
Publicado: (2020)

Efficacy, Safety, and Drug–Drug Interactions for Insomnia Therapy in COVID-19 Patients
por: Saputra, Billy Dwi, et al.
Publicado: (2022)

Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
por: Kilit, Türkan Paşalı, et al.
Publicado: (2022)

Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints
por: Vilar, Santiago, et al.
Publicado: (2013)

Drug–drug Interactions: An Overlooked Dimension of the COVID-19 Pandemic
por: Beninger, Paul
Publicado: (2023)

Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals
por: Acton, Emily K., et al.
Publicado: (2022)

Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
por: Cattaneo, Dario, et al.
Publicado: (2021)

Potential drug-drug interactions and their associated factors in hospitalized COVID-19 patients with comorbidities
por: Rahmadani, Imanda Dyah, et al.
Publicado: (2023)

505. Drug-drug Interaction Profiling of Obeldesivir, A Promising Oral Treatment for COVID-19
por: Amini, Elham, et al.
Publicado: (2023)

An update on drug-drug interactions for care of the acutely ill in the era of COVID-19
por: Patanwala, Asad E, et al.
Publicado: (2023)

Drug-drug interaction with oral antivirals for the early treatment of COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2023)

Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
por: Chen, Zhaoyan, et al.
Publicado: (2023)

Potential drug-drug interactions of antiretrovirals and antimicrobials detected by three databases
por: Vivithanaporn, Pornpun, et al.
Publicado: (2021)

Drug Interactions of Psychiatric and COVID-19 Medications
por: Mohebbi, Niayesh, et al.
Publicado: (2020)

Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience
por: Cattaneo, D., et al.
Publicado: (2021)

Quantifying Critical Care Pharmacist Interventions in COVID-19
por: Pluenneke, Jack C., et al.
Publicado: (2023)

Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021)

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview
por: Rezaee, Haleh, et al.
Publicado: (2021)

Prevalence of potential drug-drug interactions with ritonavir-containing COVID-19 therapy
por: Igho-Osagie, Ebuwa, et al.
Publicado: (2023)

Opportunities and Challenges of Using Big Data to Detect Drug‐Drug Interaction Risk
por: Quinney, Sara K.
Publicado: (2019)

Developing an animal model to detect drug–drug interactions impacting drug-induced respiratory depression()
por: Xu, Lin, et al.
Publicado: (2020)

Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications
por: Jain, Shreshta, et al.
Publicado: (2021)

Population-based screening to detect benzodiazepine drug-drug-drug interaction signals associated with unintentional traumatic injury
por: Chen, Cheng, et al.
Publicado: (2022)

Adverse drug reactions and drug interactions in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)
por: Marins, Tatiana A., et al.
Publicado: (2021)

Extracting drug-enzyme relation from literature as evidence for drug drug interaction
por: Zhang, Yaoyun, et al.
Publicado: (2016)

Potential drug–drug interactions of frequently prescribed medications in long COVID detected by two electronic databases
por: Meakleartmongkol, Theejutha, et al.
Publicado: (2023)

A Review of Daclatasvir Drug–Drug Interactions
por: Garimella, Tushar, et al.
Publicado: (2016)

High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
por: Macías, Juan, et al.
Publicado: (2020)

Drug-drug interaction with oral antivirals for early treatment of COVID-19 – Authors’ reply
por: Larsen, Carsten Schade
Publicado: (2023)

Extraction of Pharmacokinetic Evidence of Drug–Drug Interactions from the Literature
por: Kolchinsky, Artemy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c80hrlkocf5lpm8qvou4bdmiah